|Leading policy-makers and scholars explain how market forces, deregulation, and consumer choice can work to improve health care for all Americans.||
Review and Outlook: The 100 Hours Rush
The Journal reviews the legislation that Democrats have promised to pass in their first 100 hours in control of Congress, and suggest the nation deserves more of a debate on these issues than it will get.
The need for scrutiny is even more compelling on price controls for Medicare prescription drugs. Under the Medicare Part D benefit that took effect last year, private companies negotiate prices. Democrats want to allow the government to deal directly with drug companies. They argue that this would lead to lower prices for medicines, but the more likely outcome is fewer drug choices and price controls.
|home spotlight commentary research events news about contact links archives|